Atlas Trials

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

Clinical trial NCT06531447 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06531447
Sponsor
The National Center of Oncology, Azerbaijan
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2014-05-01
Primary completion
2017-11-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.